Literature DB >> 427737

Staging of cancer of the colon and cancer of the rectum.

D A Wood, G F Robbins, C Zippin, D Lum, M Stearns.   

Abstract

A retrospective analysis of 1,826 cases (924 colon, 902 rectal) from ten institutions provided the basis of this study on the staging of cancer of the colon and rectum. The general rules of the American Joint Committee on the relationship between times and the staging of cancer have been followed. These represent modifications of the originally formulated TNM system of the Union Internationale Contre Le Cancer (UICC) which has been designed as a clinical-diagnostic classification, not applicable to cancer of inaccessible sites or structures requiring postsurgical treatment pathologic assessment of therapeutically removed specimens. Inadequacies of the clinical data requested for our study required adoption of the pTNM evaluation method of classification. Multiple regression analysis of the data demonstrated a relationship between survival and the following: depth of penetration (T), status of regional lymph nodes (N), and presence or absence of distant metastasis (M). This was similar for both sites. Basically, for the rectum it was in consonance with the original Dukes' classification (A, B, and C), and was remarkably applicable to the colon. The survival data for the two sites were so similar as to suggest the use of one set of pTNM categories not only for the postsurgical-treatment pathologic evaluation, but also for the stage grouping definitions. Strongly recommended for cancer of all sites is the development of General Oncology Data Forms to be included in the clinical charts and records of all patients with cancer.

Entities:  

Mesh:

Year:  1979        PMID: 427737     DOI: 10.1002/1097-0142(197903)43:3<961::aid-cncr2820430327>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.

Authors:  J M Gilbert; K Hellmann; M Evans; P G Cassell; B Stoodley; H Ellis; C Wastell
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts.

Authors:  M L Gope; M Chun; R Gope
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

4.  The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status.

Authors:  Hae Ran Yun; Woo Yong Lee; Won Suk Lee; One Suk Lee; Yong Beom Cho; Seong Hyeon Yun; Ho-Kyung Chun
Journal:  Int J Colorectal Dis       Date:  2007-05-08       Impact factor: 2.571

Review 5.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

6.  Pelvic exenteration for locally advanced colorectal carcinoma.

Authors:  J Boey; J Wong; G B Ong
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

7.  Prognostic groups in colorectal carcinoma.

Authors:  P Hermanek; F P Gall; A Altendorf
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.